Assessing Risk of Delayed Cutaneous Drug Reactions Through T-Cell Receptor Clonality Profiling

Speciality: Dermatology


Speaker:

Saiqa Zahoor | HCP

Description:

Delayed cutaneous drug reactions are unpredictable skin responses that can develop days to weeks after exposure to certain medications. Recent advances in immunology have shown that T-cell receptor clonality profiling can help assess the risk of such reactions. By analyzing the diversity and expansion of specific T-cell clones in a patient's blood or skin, clinicians can better understand which drugs may trigger an immune response. This approach allows for more personalised and safer drug therapy, potentially reducing adverse reactions. As research progresses, T-cell receptor clonality profiling could become a valuable tool in predicting and preventing delayed cutaneous drug reactions, offering better outcomes for patients.

See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer during young adulthood carries long-term mental toll, study finds

2.

In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.

3.

Surgery after EGFR TKI shows promise in prolonging progression-free survival in metastatic NSCLC

4.

Every cancer is different because of how evolution causes drug resistance and why various cancers require various treatments.

5.

Report: High risk of lung cancer from respirable crystalline silica even below the current occupational exposure limit


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot